• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Do Antidepressants Have Any Role in Acute Bipolar Depression?
Research Update

Do Antidepressants Have Any Role in Acute Bipolar Depression?

April 14, 2023
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Marilyn J. Vaché, MD. Dr. Vaché has no financial relationships with companies related to this material.

REVIEW OF: Hu Y et al, Psychiatry Res 2022;311:114468

STUDY TYPE: Meta-analysis

Antidepressants are thought to cause mania, mixed states, and rapid cycling in bipolar disorder, but they remain the most commonly prescribed medication in this illness. The last meta-analysis on this controversial subject found a small benefit in depressive symptoms (effect size 0.17) but no change in remission or response rates with their short-term use (McGirr A et al, Lancet Psychiatry 2016;3(12):1138–1146). The current paper updates that work with 13 additional trials, adding newer studies and including some in Chinese and French.

The analysis included 19 randomized placebo-controlled trials that tested antidepressants as add-ons to mood stabilizers or antipsychotics in acute bipolar depression (not manic or mixed). The studies included 2,587 patients, only 11% (280) with bipolar II. Most studies followed them for six to 10 weeks. Investigators treated real-world patients, both inpatient and outpatient, some with substance use, psychotic symptoms, and rapid cycling. The primary outcome was response, as measured by >50% improvement in depressive rating scales or a Clinical Global Impression-Improvement score of 1–2. Secondary outcomes included remission, time to remission, adverse reactions, mood switching, and dropouts. They also compared secondary outcomes: remission rates and time to remission, adverse reactions, mood switching, and dropouts.

Response rates were available for 16 studies. In those, 59% of the subjects on antidepressants achieved response, compared with 51% on placebo (RR=1.10). Eleven studies measured remission. In those, 49% of subjects on antidepressants achieved remission, compared with 42% on placebo (RR=1.09). Neither the response nor remission rates were statistically significant. Mood switching occurred in about 5% of patients in treatment and placebo arms, and neither arm proved better at preventing adverse reactions or dropouts.

Researchers then looked at whether antidepressants performed differently when paired with a traditional mood stabilizer (lithium, valproate, or carbamazepine) vs an antipsychotic. The results for antipsychotics looked better, but close analysis showed that two of the four antipsychotic trials were industry sponsored and larger than the others, weighing the statistical outcomes in their favor.

The authors identified quality concerns in about half of the studies. Chinese researchers did not describe randomization methods and presented open-label data in eight out of 10 articles. Nonetheless, their outcomes were not significantly different from other trials.

CARLAT TAKE

Antidepressants neither help nor harm bipolar depression in the short term, at least in bipolar I disorder, which accounted for 89% of the subjects in these trials. However, longer-term studies have linked antidepressants to rapid cycling in patients with bipolar disorder.

General Psychiatry Research Update
KEYWORDS antidepressants bipolar disorder meta-analysis mood disorders
    www.thecarlatreport.com
    Issue Date: April 14, 2023
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Psychocardiology, TCPR, April/May 2023
    When Shorter Is Better
    Cardiovascular Psychiatry: Part 1
    Cardiovascular Psychiatry: Part 2
    Music for Sleep
    Do Antidepressants Have Any Role in Acute Bipolar Depression?
    L-Methylfolate May Offer Modest Boost to Antidepressants
    Can Abstaining From Social Media Help People Feel Better?
    Marginal Results for Levetiracetam in Mania
    A New Intervention for Shift-Work Disorder
    An End to YAVIS Syndrome?
    The Center Cannot Hold: My Journey Through Madness
    CME Post-Test, Psychocardiology, TCPR, April/May 2023
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.